8 assets in Female Breast Carcinoma

Therapeutic assets addressing Female Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anastrozole Female Breast Carcinoma	Ahon Pharmaceutical Co., Ltd.	P4	BBB (72)
Goserelin Female Breast Carcinoma	Ahon Pharmaceutical Co., Ltd.	P3	BB (66)
Fulvestrant Female Breast Carcinoma	Ahon Pharmaceutical Co., Ltd.	P3	BB (65)
Letrozole Female Breast Carcinoma	Ahon Pharmaceutical Co., Ltd.	P3	B (60)
Trastuzumab Deruxtecan Female Breast Carcinoma	Sun Yat-sen University	P3	B (60)
Megestrol Acetate Female Breast Carcinoma	Sun Yat-sen University	P3	B (58)
Palbociclib Female Breast Carcinoma	Wake Forest University Health Sciences	P2	CCC (53)
Dihydrotestosterone Female Breast Carcinoma	Memorial Sloan Kettering Cancer Center	Early P1	C (39)